Related Experiment Video
Updated: Jun 21, 2025

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Striking senescence with sodium transporter inhibition
Bettina Schock1, Steven O'Reilly2
1Wellcome-Woolfson Institute for Experimental Medicine, Queens University Belfast 97 Lisburn Road, Belfast, UK.
None:
Senescence is associated with multiple morbidities and therapeutic targeting of these cells is a key aim. In a recent study, Katsuumi et al. found that targeting sodium-glucose co-transporter 2 (SGLT2) promoted immune clearance of senescent cells via programmed cell death-1 ligand (PD-L1) suppression, thus promoting immunosurveillance. This could have profound implications for many age-related diseases, including cancer and frailty.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Drugs Affecting Neurotransmitter Synthesis
Desensitization and Tachyphylaxis
Resting Potential Decay
At rest, the K+ is the main ion that moves across the membrane...

